Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 71369 

1Public Law 104–191, 110 Stat. 1936 (Aug 21, 

1996), available at https://www.congress.gov/104/ 

plaws/publ191/PLAW-104publ191.pdf. 

2Public Law 111–148, 124 Stat.119, available at 

https://www.congress.gov/111/plaws/publ148/ 

PLAW-111publ148.pdf. 

participant’s public comment. Should 

you have questions during the session 

email napa@hhs.gov and someone will 

respond to your message as quickly as 

possible. 

In order to ensure accuracy, please 

submit a written copy of oral comments 

for the record by emailing napa@

hhs.gov by Wednesday, November 1, 

2023. These comments will be shared 

on the website and reflected in the 

meeting minutes. 

In lieu of oral comments, formal 

written comments may be submitted for 

the record by Wednesday, November 1, 

2023 to Helen Lamont, Ph.D., OASPE, 

200 Independence Avenue SW, Room 

424E, Washington, DC 20201. 

Comments may also be sent to napa@

hhs.gov. Those submitting written 

comments should identify themselves 

and any relevant organizational 

affiliations. 

FOR FURTHER INFORMATION CONTACT: 

Helen Lamont, 202–260–6075, 

helen.lamont@hhs.gov. Note: The 

meeting will be available to the public 

live at www.hhs.gov/live. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is given under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2, section 10(a)(1) and 

(a)(2)). Topics of the Meeting: dementia, 

risk reduction, Alzheimer’s disease. 

Procedure and Agenda: The meeting 

will be webcast at www.hhs.gov/live and 

video recordings will be added to the 

National Alzheimer’s Project Act 

website when available, after the 

meeting. 

Authority: 42 U.S.C. 11225; section 

2(e)(3) of the National Alzheimer’s 

Project Act. The panel is governed by 

provisions of Public Law 92–463, as 

amended (5 U.S.C. appendix 2), which 

sets forth standards for the formation 

and use of advisory committees. 

Dated: September 22, 2023. 

Miranda Lynch-Smith, 

Senior Official Performing the Duties of the 

Assistant Secretary for Planning and 

Evaluation, Deputy Assistant Secretary for 

Health Policy. 

[FR Doc. 2023–22752 Filed 10–13–23; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Committee on Vital and Health 

Statistics 

AGENCY: Centers for Disease Control and 

Prevention, HHS. 

ACTION: Notice of meeting (virtual); 

notice of request for information (RFI). 

SUMMARY: Pursuant to the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) announces the following 

advisory committee meeting and related 

Request for Information (RFI). This 

meeting is open to the public. The 

public is welcome to obtain the link to 

attend this meeting by following the 

instructions posted on the Committee 

website: https://ncvhs.hhs.gov/ 

meetings/full-committee-meeting-15. To 

submit comments in response to the 

RFI, please send by close of business 

January 12, 2024, to NCVHSmail@

cdc.gov, and include on the subject line: 

Response from [your organization and/ 

or name] regarding ICD–11 RFI. 

Name: National Committee on Vital 

and Health Statistics (NCVHS) Meeting. 

DATES: 

Wednesday, November 29, 2023: 10 

a.m.–5 p.m. ET. 

Thursday, November 30, 2023: 10 

a.m.–4:30 p.m. ET. 

ADDRESSES: Virtual open meeting. 

FOR FURTHER INFORMATION CONTACT: 

Substantive program information may 

be obtained from Rebecca Hines, MHS, 

Executive Secretary, NCVHS, National 

Center for Health Statistics, Centers for 

Disease Control and Prevention, 3311 

Toledo Road, Hyattsville, Maryland 

20782, or via electronic mail to vgh4@

cdc.gov; or by telephone (301) 458– 

4715. Summaries of meetings and a 

roster of Committee members are 

available on the NCVHS website https:// 

ncvhs.hhs.gov/ where further 

information including an agenda and 

instructions to access the broadcast of 

the meeting will be posted. 

Should you require reasonable 

accommodation, please telephone the 

CDC Office of Equal Employment 

Opportunity at (770) 488–3210 as soon 

as possible. 

SUPPLEMENTARY INFORMATION: 

Name: National Committee on Vital 

and Health Statistics (NCVHS). Full 

Committee Meeting. The National 

Committee on Vital and Health 

Statistics was established by Congress to 

serve as the statutory [42 U.S.C. 242k(k)] 

advisory body to the Secretary of Health 

and Human Services for health data, 

statistics, privacy, and national health 

information policy. In addition, under 

the Health Insurance Portability and 

Accountability Act of 1996 (HIPAA),1

NCVHS advises the Secretary on 

administrative simplification standards, 

including those for privacy, security, 

adoption and implementation of 

transaction standards, unique 

identifiers, code sets, and operating 

rules adopted under the Patient 

Protection and Affordable Care Act 

(ACA) 2 and HIPAA. In that capacity, 

the Committee provides advice and 

assistance to the Department and serves 

as a forum for interaction with 

interested private sector groups on 

health data issues. It fulfills important 

review and advisory functions regarding 

health data and administrative 

standards of national and international 

scope, conducts studies of prevailing 

current topics, and makes 

recommendations for improvement of 

the Nation’s health statistics and 

information systems. 

Purpose: The meeting agenda will 

include briefings from HHS officials, 

time for members to discuss and 

consider current and proposed activities 

outlined in the NCVHS 2023–24 

workplan, and hold discussions on 

several health data policy topics, 

including health care standards 

development and cybersecurity. 

The Subcommittee on Standards 

plans to hold a panel discussion on the 

approach used by Standards 

Development Organizations (SDOs) to 

evaluate and assess the readiness of new 

and updated standards prior to release 

for national implementation. This 

includes discussion on potential risks 

and impacts across existing standards, 

calculation of business cost recovery, 

and planning for the anticipated ICD–11 

implementation timeline and expected 

milestones. Additional briefings on 

related topics such as HIPAA 

enforcement also may be included on 

the agenda. 

The NCVHS Workgroup on Timely 

and Strategic Action to Inform ICD–11 

Policy will report to the full Committee 

on recent activities, including 

information learned from the ICD–11 

Expert Roundtable meeting held August 

3, 2023, and its anticipated workplan in 

the upcoming 6–12 month period. 

The Subcommittee on Privacy, 

Confidentiality, and Security will 

facilitate a discussion on proposed 

recommendations to HHS to strengthen 

the HIPAA Security Rule following 

recent Committee briefings on the topic. 

Finally, the Committee will allot time to 

discuss draft language for the 

Committee’s 2023 Report to Congress. 

The Committee will also reserve time 

on the agenda for public comment. 

Meeting times and topics are subject to 

change. Please refer to the agenda 

posted on the NCVHS website for 


ddrumheller on DSK120RN23PROD with NOTICES1
71370 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 

3 ICD–11 Overview: Key Facts, History, and 

References (September 2023): https://

ncvhs.hhs.gov/NCVHS-WG-ICD-11-OverviewSeptember-2023. 

4 ICD–11 was adopted at the World Health 

Assembly in May 2019 and Member States 

committed to start using it for mortality and 

morbidity reporting in 2022. Since 2019, early 

adopter countries, translators, and scientific groups 

have recommended further refinements to produce 

the version that is posted online today. World 

Health Organization (WHO) Press Release. 

(February 11, 2022): https://paho.org/en/news/11-2- 

2022-whos-new-international-classificationdiseases-icd-11-comes-effect. 

5WHO ICD–11 website: https://icd.who.int/en. 

6WHO ICD–11 Fact Sheet: https://icd.who.int/en/ 

docs/icd11factsheet_en.pdf. 

updates: https://ncvhs.hhs.gov/ 

meetings/full-committee-meeting-15. 

Background on ICD–11: The 

International Classification of Diseases 

(ICD) is the global standard for health 

data, clinical documentation, and 

statistical aggregation. It provides a 

common language for recording, 

reporting, and monitoring diseases, 

allowing the world to compare and 

share data in a consistent and standard 

way—among hospitals, regions, and 

countries, and over periods of time. It 

facilitates the collection and storage of 

data for analysis and evidence-based 

decision-making by enabling systematic 

recording, reporting, analysis, 

interpretation, and comparison of 

mortality and morbidity data. 

ICD–11 allows countries to count and 

identify their most pressing health 

issues using an up-to-date and clinically 

relevant classification system.3456

Governments assign ICD–11 codes to 

health conditions and accidents so data 

can be used to design effective public 

health policies and measure their 

impacts, or so that clinicians can use the 

data for recording encounters with 

patients in a standard way. 

Request for Information: This Notice 

also serves as a Request for Information 

(RFI) addressing the potential use of 

ICD–11 for morbidity coding in the U.S. 

We welcome responses from industry 

stakeholders, interested individuals and 

organizations, or any members of the 

public. The following questions are a 

guide to information the Workgroup 

would find particularly helpful, though 

respondents are invited to comment on 

any aspect of ICD–11 that they wish. 

1. Related to ICD–11 content and addressing 

U.S.-specific needs, which 

enhancements in classification content 

would be most useful? 

a. Coding to assess and address population 

health equity, social, behavioral, and 

community health 

b. Coding to measure health care quality 

and patient safety 

c. Coding for rare diseases 

d. Content on other topics? 

2. What is the potential to reduce burdens 

and improve quality/accuracy through 

the greater automation offered by the 

ICD–11 online classification systems? 

a. How might automation reduce burdens 

of clinical documentation and coding for 

reimbursement, risk adjustment, clinical 

registry, and public health reporting? 

b. What might be the role of artificial 

intelligence for your organization? 

c. What might be the role of standardized 

cross-maps to other coding systems? 

d. What other potential features could 

promote burden reduction? 

3. What standards, systems, workforce, and 

processes must change to accommodate 

ICD–11? 

a. How would your organization assess the 

cost and impact of these changes? 

b. How might technical changes such as 

clustered (post-coordinated) coding be 

implemented in your environment? 

c. What other changes are related? 

4. What are the most important 

considerations and requirements for a 

U.S. governing body for ICD–11? 

a. Developing and managing 

implementation plans and programs for 

ICD–11 in the U.S. 

b. Developing regulations or guidance for 

ICD–11 applicable to your organization. 

c. Ongoing management and maintenance 

of U.S. ICD–11 and its use. 

d. Other requirements not named above? 

5. What financial, educational, or human 

resources will be needed for: 

a. Implementing ICD–11 in your 

organization. 

b. Managing and maintaining U.S. ICD–11 

in your organization. 

c. Meeting the needs of smaller, less 

resourced, or less externally supported 

entities. 

d. What other resources not listed here may 

be needed? 

The Committee will compile 

submitted responses and consider them 

together with responses submitted in 

response to the initial ICD–11 RFI 

[https://ncvhs.hhs.gov/wp-content/ 

uploads/2023/07/RFI-ResponsesNCVHS-Workgroup-on-Timely-andStrategic-Action-to-Inform-ICD-11- 

Policy.pdf] together with input from 

subject matter experts during the August 

3, 2023, ICD–11 Expert Roundtable 

meeting [https://ncvhs.hhs.gov/ 

meetings/icd-11-workgroup-meeting/]. 

To submit comments in response to the 

RFI, please send by January 12, 2024, to 

NCVHSmail@cdc.gov and include on 

the subject line: Response from [your 

organization or name] regarding ICD–11 

RFI. 

Sharon Arnold, 

Associate Deputy Assistant Secretary, Office 

of Science and Data Policy, Office of the 

Assistant Secretary for Planning and 

Evaluation. 

[FR Doc. 2023–22753 Filed 10–13–23; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neurodegenerative Disorders and 

Aging. 

Date: November 7, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jessica Bellinger, Ph.D., 

Scientific Review Administrator, Center for 

Scientific of Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3158, 

Bethesda, MD 20892, 301–827–4446, 

bellingerjd@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Genes, Genomes and Genetics. 

Date: November 8–9, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Bethesdan Hotel, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Linda Wagner Jurata, 

Ph.D., Scientific Review Officer, The Center 

for Scientific Review, The National Institutes 

of Health, 6701 Rockledge Drive, Bethesda, 

MD 20892, (301) 496–8032, linda.jurata@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Biomedical Sensing, Measurement 

and Instrumentation. 

Date: November 8–9, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Steven Anthony Ripp, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–3010, steven.ripp@nih.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1